Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2017	Mar. 31, 2017
Current assets:
Cash	$ 129,332	$ 180,838
Prepaid expenses and other current assets	3,738	3,221
Income tax receivable	0	105
Total current assets	133,070	184,164
Deferred tax assets	0	208
Furniture and equipment, net	965	906
Other assets	2,098	0
Total assets	136,133	185,278
Current liabilities:
Accounts payable	1,354	3,329
Income tax payable	456	0
Accrued expenses	14,547	11,978
Due to Roivant Sciences Ltd. and Roivant Sciences, Inc.	731	3,030
Total current liabilities	17,088	18,337
Warrant liability	0	52
Deferred rent	326	113
Total liabilities	17,414	18,502
Commitments and contingencies (Note 7)
Shareholders’ equity:
Common shares, par value $0.000017727 per share, 564,111,242 shares authorized, 60,849,236 and 60,275,757 issued and outstanding at September 30, 2017 and March 31, 2017, respectively	1	1
Common shares subscribed	(1)	(1)
Additional paid-in capital	256,875	251,733
Accumulated other comprehensive income	288	140
Accumulated deficit	(138,444)	(85,097)
Total shareholders’ equity	118,719	166,776
Total liabilities and shareholders’ equity	$ 136,133	$ 185,278